神經幹細胞·前驅細胞產品的策略性開發 是由出版商BIOINFORMANT WORLDWIDE, LLC在2012年01月所出版的。
這份英文市場調查報告書包含113 Pages 價格從美金3495起跳。
本報告提供神經幹細胞及前驅細胞產品的市場相關調查分析，神經幹細胞研究的應用處相關最新趨勢，應用處的優先順序，神經幹細胞的各種研究用產品的種類，利用研究產品的實驗室及最終消費者簡介，專利分析，5年的市場成長預測，研究用產品的主要業者的競爭分析，對供應商的指導等彙整資料，為您概述為以下內容。
第1章 背景
第2章 應用處
- 基礎研究
- 藥物發明
- 給藥
- 神經毒性評估
- 神經移植
- 腦瘤研究
第3章 應用處的優先順序
第4章 專利
第5章 5年的市場成長預測
第6章 競爭企業:神經幹細胞·前驅細胞產品的供應商和產品提供
- Millipore, Inc.
- Stem Cell Technologies
- AlphaGenix, Inc.
- R&D Systems
- Cell Applications
- SA Biosciences
- ScienCell
- Neuromics
- Amaxa
- Invitrogen
- Sigma Aldrich
- Orion(現在不存在)
第7章 神經幹細胞·前驅細胞治療的特殊醫藥品企業
- Neuralstem, Inc
- NeuroNova AB
- NeuroGeneration
第8章 幹細胞研究的細胞各種類詳細內容
第9章 神經細胞產品的潛在最終消費者
- 學術研究實驗室
- 民間實驗室
- 商業實驗室
- 政府實驗室
第10章 產品的想法·提案
- 產品分類
- 細胞·組織
- 套件
- 各種培養基
- 生長因子
- 市場:神經幹細胞·分化後代市場
- PCR陣列
- Nucleofection工具
- 神經毒性分析
- 產品的提案
- 神經毒性分析產品
- 物種特有的機會
- 競爭不激烈的領域
- 新來源的神經幹細胞
- 神經幹細胞
第11章 總論
Abstract
Overview:
Neurogenesis is the process by which neurons are created. This process is most
active during pre-natal development when neurogenesis is responsible for
populating the growing brain. Neural stem cells (NSCs) are the self-renewing,
multipotent cells that differentiate into the main phenotypes of the nervous
system. These cell types include neurons, astrocytes, and oligodendrocytes.
Neural progenitor cells (NPCs) are the progeny of stem cell division that
normally undergo a limited number of replication cycles in vivo.
The terms neuronal and neural also need to be defined. Technically speaking,
“neuronal” means “pertaining to neurons”, and
“neural” means “pertaining to nerves, which are the cordlike
bundles of fibers made up of neurons.” Since both terms ultimately are
descriptive of neurons, the scientific community uses the terms "neuronaland
"neuralinterchangeably. The complexity of this issue is explored from a
marketing perspective within this report.
In 1992, Reynolds and Weiss were the first to isolate neural stem cells from
the striatal tissue of adult mice brain tissue, including the subventricular
zone, which is a neurogenic area. Since then, neural progenitor and stem cells
have been isolated from various areas of the adult brain, including
non-neurogenic areas like the spinal cord, and from other species, including
humans. During the development of the nervous system, neural progenitor cells
can either stay in the pool of proliferating undifferentiated cells or exit
the cell cycle and differentiate.
Over the past few years, neuronal stem and progenitor cells have become of
profound interest to the research community due to their potential to be used
in drug discovery and delivery applications, as well as for tools of neural
toxicology assessment. NSC transplantation also represents a ground-breaking
approach for treating a range of chronic neurological diseases and acute CNS
injuries, including Parkinson's, Alzheimer's and spinal cord injury, among
other conditions.
This market report focuses on recent advances in NSC research applications,
explores research priorities by market segment, highlights individual labs and
end-users of neuronal stem cell research products, explores the competitive
environment for NSC research products, and provides 5-year growth and trend
analysis. It provides detailed guidance for companies that wish to offer
strategically positioned NSC research products, including cells, kits, assays,
and related media and reagents.
This market report includes:
- Recent advances in NSC research applications
- Research priorities by market segment
- Competitive analysis of NSC research supply companies
- Segmentation of existing NSC products
- Individual labs and end-users of NSC research products
- Patent analysis
- Overview of specialty pharmaceutical companies developing NSC therapies
- 5-year market growth projections and trend analysis
- Detailed guidance for companies that wish to offer strategically
positioned NSC research products, including cells, kits, assays, media and
reagents
- And much more
Trailing 10 Year Analysis of Scientific Publications Rates (2001-2010)
Table of Contents
I. Background
- A. Language and Definitions
- 1. Neurogenesis
- 2. Neuronal vs. Neural
- 3. Neural Stem Cells (NSCs) vs. Neural Progenitor Cells (NPCs)
- C. Overview of Neural Stem and Progenitor Cell Regulation
- 1. In vitro Regulation
- 2. In vivo Regulation
II. Applications
- A. Basic Research
- 1. Developmental Biology
- 2. Adult Biology
- B. Drug Discovery Applications
- C. Drug Delivery Applications
- D. Neural Toxicology Assessment
- E. Neural Transplantation
- F. Brain Tumor Research
III. Application Priorities
- A. Overall
- 1. Cell-Based Therapies
- 2. Standardized Neural Toxicology Assays
- B. Breakdown of Neural Stem Cell Research by Disorder
- C. By Segment
- 1. Academic
- 2. Biotech
- 3. Pharma
IV. Patents
- A. Key U.S. Neuronal Stem and Progenitor Cell Patents
- B. Additional U.S. Patents
- C. Additional European Patents
V. Projected 5-Year Market Growth
- A. Scientific Publication Analysis
- 1. Neural vs. Neuronal Products
- 2. Stem vs. Progenitor Cell Products
- 3. Five-Year Growth Projections
- 4. Conclusions from Data
- B. Grant Rate Analysis
- 1. Neural vs. Neuronal Products
- 2. Stem vs. Progenitor Cell Products
- 3. Five-Year Growth Projections
- 4. Conclusions from Data
- C. Patent Rate Analysis
- 1. Neural vs. Neuronal Products
- 2. Stem vs. Progenitor Cell Products
- 3. Five-Year Growth Projections
- 4. Conclusions from Data
VI. Competitors: Suppliers of Neural Stem & Progenitor Cell Products, Including Products Offered
- A. Millipore, Inc.
- B. Stem Cell Technologies
- C. AlphaGenix, Inc.
- D. R&D Systems
- E. Cell Applications
- F. SA Biosciences
- G. ScienCell
- H. Neuromics
- I. Amaxa
- J. Invitrogen
- K. Sigma Aldrich
- L. Orion (no longer in existence)
VII. Specialty Pharmaceutical Companies: Neural Stem & Progenitor Cell Therapies
- A. Neuralstem, Inc
- B. NeuroNova AB
- C. NeuroGeneration
VIII. Breakdown of Stem Cell Research Activity by Cell Type
IX. Potential End-Users of Neural Stem Cell Products
- A. Academic Labs
- B. Private Labs
- C. Commercial Labs
- D. Government Labs
X. Product Ideas & Suggestions
- A. Product Categories
- 1. Cells & Tissue
- a. Fetal-Derived Neural Stem Cells
- b. Adult-Derived Neural Stem Cells
- c. Fetal-Derived Immortalized Neural Stem Cells
- d. Cryopreserved Embryonic Neurospheres
- e. Embryonic Stem Cell Derived Neural Progenitors
- f. Embryonic Primary Neuronal Tissue
- g. NSC Differentiated Progeny Cells
- 2. Kits
- a. Kits for Analysis of NSC Differentiated Progeny
- b. Stem Cell Functional Kits
- c. Neuronal Stem Cell Phenotyping Kits
- d. Neural Stem Cell Expansion Kits
- e. Neural Stem Cell Differentiation Kits
- f. Neural Stem Cell Blotting Kits
- 3. Media: Maintenance, Differentiation, Expansion, & Freezing Medium
- 4. Growth Factors
- 5. Markets: Markers for Neural Stem Cells & Differentiated Progeny
- 6. PCR Arrays
- 7. Nucleofection Tools
- 8. Neural Toxicity Assessment
- B. Product Suggestions
- 1. Neural Toxicity Assessment Products (an untapped niche)
- 2. Species-Specific Opportunities
- 3. Areas of Underdeveloped Competition
- 4. NSC Derived from Novel Sources
- 5. Neural Rosette Cells (R-NSCs)
XI. Conclusions
